Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check5 days agoChange DetectedThe page now shows an updated site revision line: Revision: v3.3.4 (replacing v3.3.3). This is a minor metadata update and does not affect the clinical trial details, eligibility criteria, enrollment, or results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded: Revision: v3.3.3 and removed: HHS Vulnerability Disclosure and Revision: v3.3.2. The changes pertain to site-wide release notes/footer and do not affect the Study Details content or its purpose.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedA notice about government funding status and potential delays at the top of the page was removed. The rest of the study details and navigation appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedNo substantive changes to the study details were detected; the page content remains the same aside from minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check105 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference4%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.